Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Sadaf Mohtashami

Sadaf Mohtashami

McGill University, Canada

Title: Expression and proteomic analyses of kif1a/25b in hereditary sensory and autonomic neuropathies type II

Biography

Biography: Sadaf Mohtashami

Abstract

Hereditary sensory and autonomic neuropathies form a group of genetic disorders characterized by variable sensory and autonomic dysfunctions. HSAN type II (HSANII) is a debilitating subtype manifesting in early childhood with distal numbness and loss of pain, temperature and touch. The first cluster of HSANII cases was reported in eastern Canada, with half the patients of French-Canadian descent. Our laboratory has reported truncating mutations in a nervous-tissue-specific exon (HSN2) of the WNK1 gene. The WNK1 isoform containing the alternatively spliced exon (HSN2) is referred to as the WNK1/HSN2 isoform. Interestingly the protein region encoded by the alternatively spliced exon was found to interact with a particular isoform of another HSANII causative gene, KIF1A. The HSANII-causing KIF1A isoform is referred to as KIF1A/25B since disease-causing mutations were exclusively found in the alternative exon “25B”. KIF1A belongs to a superfamily of microtubule-dependent proteins that mediate specific and diverse motile processes within the cell.

Materials & Methods: The expression profile of KIF1A/25B across the nervous system is determined by performing WB immunodetection using tissues from wild-type mice and a rabbit antiserum. The function of the protein encoded by exon 25B is assessed through a profiling of its interacting partners by performing co-immunoprecipitation for full-length KIF1A/25B protein, full-length KIF1A/25B minus exon 25B, the protein that correspond to exon 25B and EGFP protein as a negative control. Positive interactions are confirmed using liquid chromatography–mass spectrometry.

Results: KIF1A/25B is the transit system through which WNK1/HSN2 traffics within the cells and offers the two proteins an opportunity to interact with other cellular elements relevant to the sensory and nociceptive aspects of HSANII.

Conclusions: This study answers fundamental questions regarding the molecular pathophysiology of HSANII, though our findings have an impact on the understanding of other neuropathies and of normal neuronal processing.